Clinical Trials Insight: 700018732
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2007
At a glance
- Drugs KOS 1584 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Kosan Biosciences
- 04 Jun 2007 Interim results were presented at the 2007 American Society of Clinical Oncology (ASCO) meeting.
- 28 Feb 2007 Status change recruiting to in progress.
- 22 Nov 2006 18th EORTC-NCI-AACR Symposium